Clinical Trial Update: An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial evaluating alirocumab in children and adolescents with heterozygous familial hypercholesterolemia has been completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolaemia | Phase 2 | Status: COMPLETED | Results posted: 2019-09-06